Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Philip Connolly

Latest From Philip Connolly

R&D collaborations set for a quiet 2013

If past experience is anything to go by, R&D collaborations in animal health are set to fall in 2013 (see Animal Health Partnerships graph below).

Boehringer Ingelheim Animal Health Merial

What price know-how?

How has Piedmont Pharmaceuticals taken advantage of a consolidating animal health industry? Philip Connolly interviewed the company's chief executive Roland Johnson to find out

Policy & Regulation Dermatology

Likarda cautious on dog diabetes research breakthrough

Kansas-based regenerative medicine specialist Likarda has warned recent gene therapy research into a cure for canine diabetes is exciting but is not yet a viable treatment.

Canine R&D

Health inspectors lack knowledge of zoonoses, says study

Canada's 2,600 Public Health Inspectors (PHIs) play a pivotal role in the control of infectious disease outbreaks.

Policy & Regulation R&D

Mucosal route has potential against swine disease

Ohio State University (OSU) scientists believe they have demonstrated in swine the proof that intranasal vaccination works against porcine respiratory and reproductive system (PRRS) disease.

Porcine Vaccines

Ivermectin shown to inhibit bacteria

Industry eyebrows have been raised at a research finding that ivermectin, the long established antiparasitic compound, can also be effective against bacteria.

Antiparasitics R&D
See All